The goal of this research proposal is to develop a novel means for obtaining peptides that would serve as vaccine leads against infection by HIV-1. Our strategy begins with a repertoire of antibodies that is specifically designed to mimic the structures of Abs that are elicited by immunization with peptide conjugates. Selected human germline V genes will encode this repertoire of """"""""anti-peptide-like"""""""" Abs, so that it will mimic a subset of the """"""""natural"""""""" repertoire that is typically elicited against peptide-immunogens. The repertoire will be expressed and displayed as Fab-fusions to filamentous phage, and will be screened against recombinant HIV-1 envelope protein to find binding Fabs. These Fabs, in turn, should be predisposed to bind peptides, and, on immunization, they should be elicited by peptide-conjugate vaccines. Thus, when such Fabs are used to screen a peptide library, """"""""immunogenic-mimic"""""""" peptides should be found that will both cross-react with the Fabs and elicit target-antigen-binding Abs when used as immunogens. We propose to apply these concepts in our ongoing search for peptide leads for a vaccine that will produce broadly neutralizing Abs against HIV-1, following the specific aims: 1. Construct a phage-displayed Fab library whose design is based on human germline V-genes that appear in the """"""""anti-peptide"""""""" antibodies. 2. Validate the phage-displayed Fab library for (i) its ability to produce binding Fabs against a panel of """"""""target"""""""" peptide and protein antigens; (ii) the ability of those antigen-binding Fabs to bind to peptides, and (iii) the ability of the Fab-binding peptides to elicit Ab responses that bind to the corresponding target antigen. 3. Screen the Fab library with recombinant HIV- 1 envelope protein and intact HIV-1 particles to obtain specific HIV-1-binding Fabs; and characterize the Fabs for their ability to bind to and neutralize a panel of HIV-1 strains and primary isolates. 4. Screen a panel of 16 phage-displayed peptide libraries with the HIV- 1 binding Fabs to obtain peptide ligands. 5. Determine whether the peptide ligands elicit immune responses that recognize Env proteins and neutralize HIV-1. By this means, we hope to develop a new means of targeting peptide vaccines against neutralizing sites on HIV- l.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Exploratory/Developmental Grants (R21)
Project #
5R21AI046303-02
Application #
6170929
Study Section
Special Emphasis Panel (ZRG1-VACC (03))
Program Officer
Bradac, James A
Project Start
1999-09-30
Project End
2002-08-31
Budget Start
2000-09-01
Budget End
2002-08-31
Support Year
2
Fiscal Year
2000
Total Cost
$157,500
Indirect Cost
Name
Simon Fraser University
Department
Type
DUNS #
208032946
City
Burnaby
State
BC
Country
Canada
Zip Code
V5 1-S6
Irving, M B; Pan, O; Scott, J K (2001) Random-peptide libraries and antigen-fragment libraries for epitope mapping and the development of vaccines and diagnostics. Curr Opin Chem Biol 5:314-24
Scott, J K; Huang, S F; Gangadhar, B P et al. (2001) Evidence that a protein-protein interaction 'hot spot' on heterotrimeric G protein betagamma subunits is used for recognition of a subclass of effectors. EMBO J 20:767-76
Zwick, M B; Shen, J; Scott, J K (2000) Homodimeric peptides displayed by the major coat protein of filamentous phage. J Mol Biol 300:307-20
Yu, M W; Scott, J K; Fournier, A et al. (2000) Characterization of murine coronavirus neutralization epitopes with phage-displayed peptides. Virology 271:182-96
Zwick, M B; Shen, J; Scott, J K (1998) Phage-displayed peptide libraries. Curr Opin Biotechnol 9:427-36
Zwick, M B; Bonnycastle, L L; Noren, K A et al. (1998) The maltose-binding protein as a scaffold for monovalent display of peptides derived from phage libraries. Anal Biochem 264:87-97